Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock
Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
ECMO support is an ultimate ratio therapy for patients in refractory cardiogenic shock and is linked to high mortality. We assessed the dynamic characteristics of lactate during ECMO therapy and its predictive role on 30-day mortality.
Data were retrospectively collected in all patients receiving ECMO support longer than 48h for cardiogenic shoc...
Alternative Titles
Full title
Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1915876631
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1915876631
Other Identifiers
ISSN
0883-9441
E-ISSN
1557-8615
DOI
10.1016/j.jcrc.2017.06.022
